glp-1 retatrutide Weight Loss Blog – Maryland Trim Clinic How Retatrutide Works
Description
From a diabetology perspective, a reasonable approach involves substituting GLP-1 RA therapy with an alternative antidiabetic agent
No dependence on remaining beta cell function
Among users of both semaglutide and tirzepatide, the study details that 36.9% reported nausea, 16.7% fatigue, 16.3% vomiting, 15.3% constipation, and 12.6% diarrhea
Regular monitoring of kidney function during treatment is recommended to identify and manage potential complications early
01053-X/asset/826330f0-5581-4d6d-8f45-2192fe6ac242/main.assets/gr2_lrg.jpg)
doi: 10.2147/JIR.S84993 42 ZhaoYYChenLHHuangLLiYZYangCZhuYet al
doi: 10.1002/oby.22274
